Login / Signup

Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.

Jaco VoorhamSimonetta BaldiLuigi SantoroMarjan KerkhofMarco ContoliLeonardo M FabbriHuib A M KerstjensJosé Luis López-CamposNicholas RocheDave SinghClaus F VogelmeierDavid J Price
Published in: International journal of chronic obstructive pulmonary disease (2020)
This study found that stepping up to extrafine BDP/FF from no maintenance or monotherapy was not inferior to stepping up to double bronchodilation therapy in patients with a history of exacerbations.
Keyphrases
  • chronic obstructive pulmonary disease
  • randomized controlled trial
  • stem cells
  • mesenchymal stem cells
  • lung function
  • open label
  • cell therapy
  • combination therapy